Lumen Technologies (LUMN) director receives 25,197-share restricted stock grant

Rhea-AI Filing Summary

Capossela Christopher C reported acquisition or exercise transactions in this Form 4 filing.

Lumen Technologies director Christopher C. Capossela received a grant of 25,197 shares of common stock as a restricted stock award. The grant is valued at $9.44 per share and will vest on May 21, 2027. After this award, he holds 92,199 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Capossela Christopher C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	25,197	$9.44	$238K

Holdings After Transaction: Common Stock — 92,199 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 25,197 shares Grant value per share: $9.44 per share Total shares after grant: 92,199 shares +1 more

4 metrics

Restricted stock grant 25,197 shares Award of common stock to director on May 21, 2026

Grant value per share $9.44 per share Value assigned to restricted stock award

Total shares after grant 92,199 shares Director’s direct holdings following the transaction

Vesting date May 21, 2027 Restricted stock grant vesting schedule

Key Terms

restricted stock, vest, grant, award, or other acquisition

3 terms

restricted stock financial

"This grant of restricted stock will vest on May 21, 2027."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

vest financial

"This grant of restricted stock will vest on May 21, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Capossela Christopher C

(Last) (First) (Middle)

100 CENTURYLINK DR

(Street)

MONROE LOUISIANA 71203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lumen Technologies, Inc. [ LUMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A(1)		25,197	A	$9.44	92,199	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant of restricted stock will vest on May 21, 2027.

Remarks:

	/s/ Cory Smith, as Attorney-in-Fact for Christopher Capossela	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Lumen (LUMN) director Christopher Capossela report in this Form 4?

Christopher C. Capossela reported receiving a grant of 25,197 shares of Lumen common stock as a restricted stock award. This is a compensation-related acquisition, not an open-market purchase or sale of shares.

At what price was Christopher Capossela’s Lumen (LUMN) restricted stock grant valued?

The restricted stock grant to Christopher C. Capossela was valued at $9.44 per share. This value reflects the grant price used for the award, rather than a price paid by him in an open-market transaction.

When will Christopher Capossela’s new Lumen (LUMN) restricted shares vest?

The newly granted restricted stock to Christopher C. Capossela will vest on May 21, 2027. Vesting means the shares become fully owned and transferable, subject to any remaining company or plan conditions at that time.

How many Lumen (LUMN) shares does Christopher Capossela hold after this Form 4 transaction?

Following the restricted stock award, Christopher C. Capossela holds 92,199 shares of Lumen common stock directly. This total includes the 25,197 newly granted restricted shares reported in the Form 4 filing.

Was Christopher Capossela’s Lumen (LUMN) Form 4 a market buy or sell?

The Form 4 reflects a grant or award acquisition, not a market buy or sell. Christopher C. Capossela received 25,197 restricted shares as compensation, with no open-market purchase or sale reported in this filing.